These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25755688)

  • 1. Genomic and non-genomic effects of glucocorticoids: implications for breast cancer.
    Mitre-Aguilar IB; Cabrera-Quintero AJ; Zentella-Dehesa A
    Int J Clin Exp Pathol; 2015; 8(1):1-10. PubMed ID: 25755688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue.
    Vilasco M; Communal L; Hugon-Rodin J; Penault-Llorca F; Mourra N; Wu Z; Forgez P; Gompel A;
    Breast Cancer Res Treat; 2013 Nov; 142(2):283-96. PubMed ID: 24166279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element.
    Flick MB; Sapi E; Kacinski BM
    J Cell Biochem; 2002; 85(1):10-23. PubMed ID: 11891846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
    Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From an enhanceosome to a repressosome: molecular antagonism between glucocorticoids and EGF leads to inhibition of wound healing.
    Lee B; Vouthounis C; Stojadinovic O; Brem H; Im M; Tomic-Canic M
    J Mol Biol; 2005 Feb; 345(5):1083-97. PubMed ID: 15644206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
    Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
    Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
    He L; Li D; Hou KZ; Liu YP
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways.
    Ayroldi E; Cannarile L; Migliorati G; Nocentini G; Delfino DV; Riccardi C
    FASEB J; 2012 Dec; 26(12):4805-20. PubMed ID: 22954589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
    Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
    Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells.
    Toy EP; Lamb T; Azodi M; Roy WJ; Woo HH; Chambers SK
    Breast Cancer Res Treat; 2011 Sep; 129(2):411-9. PubMed ID: 21063905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.
    Miller AL; Webb MS; Copik AJ; Wang Y; Johnson BH; Kumar R; Thompson EB
    Mol Endocrinol; 2005 Jun; 19(6):1569-83. PubMed ID: 15817653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of extracellular signal-regulated kinase (ERK) signaling participates in repression of nuclear factor (NF)-kappaB activity by glucocorticoids.
    Bladh LG; Johansson-Haque K; Rafter I; Nilsson S; Okret S
    Biochim Biophys Acta; 2009 Mar; 1793(3):439-46. PubMed ID: 19110010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of action of glucocorticoids].
    Dejean C; Richard D
    Rev Med Interne; 2013 May; 34(5):264-8. PubMed ID: 23498716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer.
    Chen Z; Lan X; Wu D; Sunkel B; Ye Z; Huang J; Liu Z; Clinton SK; Jin VX; Wang Q
    Nat Commun; 2015 Sep; 6():8323. PubMed ID: 26374485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
    Medh RD; Saeed MF; Johnson BH; Thompson EB
    Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy.
    Orqueda AJ; Dansey MV; Español A; Veleiro AS; Bal de Kier Joffé E; Sales ME; Burton G; Pecci A
    Biochem Pharmacol; 2014 Jun; 89(4):526-35. PubMed ID: 24735610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained interleukin-1β exposure modulates multiple steps in glucocorticoid receptor signaling, promoting split-resistance to the transactivation of prominent anti-inflammatory genes by glucocorticoids.
    Escoll P; Ranz I; Muñoz-Antón N; van-den-Rym A; Alvarez-Mon M; Martínez-Alonso C; Sanz E; de-la-Hera A
    Mediators Inflamm; 2015; 2015():347965. PubMed ID: 25977599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
    Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
    Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.
    Martens C; Bilodeau S; Maira M; Gauthier Y; Drouin J
    Mol Endocrinol; 2005 Apr; 19(4):885-97. PubMed ID: 15591535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by insulin of glucocorticoid-induced gene transcription: involvement of the ligand-binding domain of the glucocorticoid receptor and independence from the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways.
    Pierreux CE; Ursø B; De Meyts P; Rousseau GG; Lemaigre FP
    Mol Endocrinol; 1998 Sep; 12(9):1343-54. PubMed ID: 9731703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.